The portal uses cookies to provide service functions such as “Bookmark” and to improve website usage. Information and opt-out options can be found in the cookie settings in the privacy policy.

Search

8-530.d0:

Nuclear medicine therapy: Therapy with unsealed radionuclides: Intravenous radioligand therapy: Radiotherapy with Lutetium‑177‑PSMA ligands

You were treated with a radioactive drug.

Radioactive drugs emit radiation. The intention is for the radiation to damage pathologically altered cells in the body. Radioactive drugs are used for tumors, among other things. The tissue in the body is made up of cells. A tumor disorder involves the cells multiplying more than normal. This results in abnormal or excess tissue forming. A tumor can be benign or malignant.

Depending on type, task and origin, the cells of the body have typical proteins on their surface. A protein is only found on prostate cells, for example. This protein is much more present on tumor cells of the prostate than on healthy prostate cells.

You have had a radioactive drug administered via a blood vessel. The drug spreads through the body with the blood. It recognizes the protein on the surface of tumor cells of the prostate and binds to it. The radioactive drug accumulates in this area of the prostate and emits radiation.

Additional indicator

If necessary, additional letters are appended to OPS codes to indicate which side of the body is affected.

  • L: Left
  • R: Right
  • B: Both sides

Further information

Note

Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.

Source

Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).